Elizabeth A. Barrett
President, CEO & DirectorMs. Elizabeth A. Barrett, also known as Liz, has been President, Chief Executive Officer and Director of UroGen Pharma Ltd. since January 3, 2019. She has been a Director at Allogene Therapeutics, Inc. since July 2021. She serves as President and Chief Executive Officer at Urogen Pharma, Inc since january 2019. She served as Chief Executive Officer of Novartis Oncology at Novartis AG since February 1, 2018 until December 31, 2018. She serves as Director at LifeSci Acquisition II Corp. since November 20, 2020. She is a highly regarded industry leader with extensive experience leading business organizations and Fortune 500 pharmaceutical companies. Ms. Barrett served as global President of oncology at Pfizer Inc. from 2015 to 2018. Ms. Barrett served as the Regional President of US Oncology Business Unit at Pfizer Inc. since March 23, 2009. Since joining Pfizer in 2009, she has held other leadership positions, including President of Global Innovative Pharma for Europe, President of the specialty care business unit for North America and President of United States oncology. Ms. Barrett has management expertise and a proven track record in building profitable organizations, working in multi-national companies with international experience and launching and expanding new businesses. She served as Vice President & General Manager for Oncology Business Unit at Cephalon Inc. from 2006 to 2009, where she successfully launched it into oncology in an integrated business unit. Ms. Barrett oversaw the marketing, sales and medical affairs organizations and was responsible for developing the short- and long-term plans to build an oncology business. Her previous oncology experience also includes managing Johnson & Johnson’s cancer therapeutics business and overseeing its new business development and licensing and acquisitions from 1993 to 2006. At Johnson & Johnson she also served as Worldwide Vice President of Sales and Marketing for Veridex, LLC and Vice President of the Critical Care and Surgery Franchise for Ortho Biotech, Inc. She served as an Independent Director of Sage Therapeutics, Inc. since January 22, 2019 until July 31, 2025. Ms. Barrett joined the Sage Therapeutics, Inc. on January 22, 2019. Ms. Barrett has received numerous awards from industry organizations including TWIN (Tribute to Women in the Industry), DTC Marketer of the Year, VP Sales/Marketing Award, HBA Rising Star, Women’s Leadership Initiative Ambassador and Outstanding Marketer of the Year. She started her career at Kraft Foods Group Inc. in 1984. Ms. Barrett received an M.B.A. degree in Business Administration-Marketing from Saint Joseph’s University and a B.S. from the University of Louisiana.
Positions
- Company NameUroGen Pharma Ltd.Stock CodeURGNPositionPresident, CEO & DirectorColleagues
- ASArie S. BelldegrunIndependent Chairman
- JDJason Drew SmithGeneral Counsel, Chief Compliance Officer & Corporate Secretary
- MPMark P. SchoenbergChief Medical Officer
- CDChristopher DegnanChief Financial Officer
- VIVincent I. PerroneSenior Director of Investor Relations
- HLHerbert LeporChairman of Scientific Advisory Board
- CMCynthia Marie ButittaIndependent Director
- LSLeana S. WenIndependent Director
